• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻成分重要吗?Δ-9-四氢大麻酚和大麻二酚对人类认知的不同影响。

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition.

作者信息

Colizzi Marco, Bhattacharyya Sagnik

机构信息

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF UK.

出版信息

Curr Addict Rep. 2017;4(2):62-74. doi: 10.1007/s40429-017-0142-2. Epub 2017 Apr 29.

DOI:10.1007/s40429-017-0142-2
PMID:28580227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5435777/
Abstract

PURPOSE OF REVIEW

The lack of clarity about the effect of cannabis use on cognition may be attributable to the considerable heterogeneity among studies in terms of cannabis composition. This article selectively reviews studies examining the distinctive effects of cannabinoids on human cognition, particularly those of delta-9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD).

RECENT FINDINGS

Research indicates that ∆9-THC administration acutely impairs cognition, particularly memory and emotional processing. Limited evidence suggests that CBD administration might improve cognition in cannabis users but not in individuals with neuropsychiatric disorders. Moreover, studies indicate that some acute Δ9-THC-induced cognitive impairments may be prevented if Δ9-THC is administered in combination or following CBD treatment. Δ9-THC and CBD have also shown opposite effects on cognition-related brain activation, possibly reflecting their antagonistic behavioral effects.

SUMMARY

Research suggests greater cognitive impairments in individuals when exposed to high ∆9-THC or low CBD cannabis. It is unclear whether at specific concentrations CBD might outweigh any harmful effects of Δ9-THC on cognition.

摘要

综述目的

大麻使用对认知的影响尚不明确,这可能归因于不同研究中大麻成分存在显著差异。本文选择性回顾了关于大麻素对人类认知独特影响的研究,尤其是Δ9-四氢大麻酚(Δ9-THC)和大麻二酚(CBD)的相关研究。

最新发现

研究表明,急性给予Δ9-THC会损害认知,尤其是记忆和情绪处理。有限的证据表明,给予CBD可能改善大麻使用者的认知,但对患有神经精神疾病的个体无效。此外,研究表明,如果Δ9-THC与CBD联合使用或在CBD治疗后使用,一些急性Δ9-THC引起的认知障碍可能会得到预防。Δ9-THC和CBD对与认知相关的大脑激活也表现出相反的作用,这可能反映了它们的拮抗行为效应。

总结

研究表明,接触高Δ9-THC或低CBD大麻的个体存在更严重的认知障碍。目前尚不清楚在特定浓度下,CBD是否能抵消Δ9-THC对认知的任何有害影响。

相似文献

1
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition.大麻成分重要吗?Δ-9-四氢大麻酚和大麻二酚对人类认知的不同影响。
Curr Addict Rep. 2017;4(2):62-74. doi: 10.1007/s40429-017-0142-2. Epub 2017 Apr 29.
2
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition.解析大麻成分对精神病和认知的致幻及治疗作用
Front Psychol. 2020 May 14;11:833. doi: 10.3389/fpsyg.2020.00833. eCollection 2020.
3
The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study.大麻二酚和 δ-9-四氢大麻酚对社会认知的影响:一项自然主义对照研究。
Cannabis Cannabinoid Res. 2024 Feb;9(1):230-240. doi: 10.1089/can.2022.0037. Epub 2022 Jul 26.
4
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.δ-9-四氢大麻酚、大麻二酚及其组合对面部表情识别的急性影响:一项针对大麻使用者的随机、双盲、安慰剂对照研究。
Eur Neuropsychopharmacol. 2015 Mar;25(3):325-34. doi: 10.1016/j.euroneuro.2014.11.014. Epub 2014 Dec 5.
5
A randomised controlled trial of vaporised Δ-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.一项随机对照试验研究了在频繁和不频繁使用大麻的人群中单独使用和联合使用蒸气化 Δ-四氢大麻酚和大麻二酚的效果:急性中毒效应。
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17-35. doi: 10.1007/s00406-019-00978-2. Epub 2019 Jan 19.
6
Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.评估口服给予 Δ9-四氢大麻酚与大麻二酚联合使用对健康成年人中 Δ9-四氢大麻酚药代动力学和药效学的影响:一项随机临床试验。
JAMA Netw Open. 2023 Feb 1;6(2):e2254752. doi: 10.1001/jamanetworkopen.2022.54752.
7
Acute effects of Δ-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity.Δ-四氢大麻酚和大麻二酚对听觉失配负波的急性效应。
Psychopharmacology (Berl). 2022 May;239(5):1409-1424. doi: 10.1007/s00213-021-05997-3. Epub 2021 Nov 1.
8
A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol.一项关于δ-8-四氢大麻酚相对于δ-9-四氢大麻酚和大麻二酚主观效果的众包调查研究。
Exp Clin Psychopharmacol. 2023 Apr;31(2):312-317. doi: 10.1037/pha0000565. Epub 2022 Apr 25.
9
Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.急性口服Δ9-四氢大麻酚和标准化大麻提取物对健康志愿者听觉P300事件相关电位的影响。
Eur Neuropsychopharmacol. 2008 Aug;18(8):569-77. doi: 10.1016/j.euroneuro.2008.04.008. Epub 2008 Jun 10.
10
Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.利用 BMD 方法推导与电子烟液相关的可接受的大麻二酚(CBD)和四氢大麻酚(THC)日摄入量。
Front Biosci (Landmark Ed). 2022 Jul 25;27(8):228. doi: 10.31083/j.fbl2708228.

引用本文的文献

1
Willingness to use a drug checking service for cannabis and cannabis-based products: results from an online survey of people who regularly use cannabis in France.使用大麻及大麻制品药物检测服务的意愿:法国定期使用大麻人群在线调查结果
Harm Reduct J. 2025 Jul 19;22(1):126. doi: 10.1186/s12954-025-01274-0.
2
Cannabis and Cognitive Function in Multiple Sclerosis: Findings From a Large Consecutive Clinical Sample.大麻与多发性硬化症的认知功能:来自大型连续临床样本的研究结果
Eur J Neurol. 2025 Jul;32(7):e70142. doi: 10.1111/ene.70142.
3
Exploring The Contours: Navigating Cannabis Use Among Older Adults.探索概况:老年人使用大麻的情况剖析
J Brown Hosp Med. 2024 Jul 1;3(3):120951. doi: 10.56305/001c.120951. eCollection 2024.
4
Cannabidiol in Foods and Food Supplements: Evaluation of Health Risks and Health Claims.食品及食品补充剂中的大麻二酚:健康风险与健康声明评估
Nutrients. 2025 Jan 29;17(3):489. doi: 10.3390/nu17030489.
5
Does cannabis affect cognitive functioning in patients with schizophrenia?大麻对精神分裂症患者的认知功能有影响吗?
Schizophr Res Cogn. 2023 Dec 20;36:100299. doi: 10.1016/j.scog.2023.100299. eCollection 2024 Jun.
6
Impact of Low-Dose Dronabinol Therapy on Cognitive Function in Cancer Patients Receiving Palliative Care: A Case-Series Intervention Study.低剂量屈大麻酚疗法对接受姑息治疗的癌症患者认知功能的影响:一项病例系列干预研究。
Palliat Med Rep. 2023 Dec 7;4(1):326-333. doi: 10.1089/pmr.2023.0024. eCollection 2023.
7
Δ9-Tetrahydrocannabinol does not upregulate an aversive dopamine receptor mechanism in adolescent brain unlike in adults.与成年人不同,Δ9-四氢大麻酚不会上调青少年大脑中的厌恶多巴胺受体机制。
Curr Res Neurobiol. 2023 Sep 4;5:100107. doi: 10.1016/j.crneur.2023.100107. eCollection 2023.
8
Cannabis smoke suppresses antiviral immune responses to influenza A in mice.大麻烟雾会抑制小鼠对甲型流感的抗病毒免疫反应。
ERJ Open Res. 2023 Nov 27;9(6). doi: 10.1183/23120541.00219-2023. eCollection 2023 Nov.
9
The Role of Hemp ( L.) as a Functional Food in Vegetarian Nutrition.大麻(L.)作为功能性食品在素食营养中的作用。
Foods. 2023 Sep 20;12(18):3505. doi: 10.3390/foods12183505.
10
Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example.我们能否利用公共数据库来填补精神卫生流行病学中的关键空白?以英国为例,测试大麻与精神病之间的关联。
Epidemiol Psychiatr Sci. 2023 Jun 15;32:e40. doi: 10.1017/S2045796023000537.

本文引用的文献

1
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia.大麻二酚对认知功能影响的系统评价:与精神分裂症的相关性。
Neurosci Biobehav Rev. 2017 Jan;72:310-324. doi: 10.1016/j.neubiorev.2016.11.012. Epub 2016 Nov 22.
2
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function.《草丛中的光彩?一项评估医用大麻对执行功能影响的试点研究》
Front Pharmacol. 2016 Oct 13;7:355. doi: 10.3389/fphar.2016.00355. eCollection 2016.
3
Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis: A Quasi-Experimental Investigation Within an Observational Study.首发精神病患者持续使用大麻与复发风险的相关性:一项基于观察性研究的准实验研究。
JAMA Psychiatry. 2016 Nov 1;73(11):1173-1179. doi: 10.1001/jamapsychiatry.2016.2427.
4
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.大麻使用的持续时间、频率和类型对精神病发作后头两年复发的影响:一项观察性研究。
Lancet Psychiatry. 2016 Oct;3(10):947-953. doi: 10.1016/S2215-0366(16)30188-2. Epub 2016 Aug 23.
5
Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case-control study.大麻使用者中DRD2与AKT1基因变异对精神病风险的相互作用:一项病例对照研究。
NPJ Schizophr. 2015 Jul 1;1:15025. doi: 10.1038/npjschz.2015.25. eCollection 2015.
6
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use.工作记忆期间的前额叶活动受CB1和COX2编码基因变异的相互作用调节,并与大麻使用频率相关。
Cortex. 2016 Aug;81:231-8. doi: 10.1016/j.cortex.2016.05.010. Epub 2016 May 21.
7
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence.大麻对大脑中谷氨酸信号的影响:人类和动物证据的系统评价。
Neurosci Biobehav Rev. 2016 May;64:359-81. doi: 10.1016/j.neubiorev.2016.03.010. Epub 2016 Mar 14.
8
Continuity of cannabis use and violent offending over the life course.大麻使用与一生中暴力犯罪的连续性。
Psychol Med. 2016 Jun;46(8):1663-77. doi: 10.1017/S0033291715003001. Epub 2016 Mar 10.
9
Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study.首次发作精神病中大麻使用与住院及抗精神病治疗失败的关联:一项观察性研究。
BMJ Open. 2016 Mar 3;6(3):e009888. doi: 10.1136/bmjopen-2015-009888.
10
Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States.过去20年(1995 - 2014年)大麻效力的变化:美国当前数据分析
Biol Psychiatry. 2016 Apr 1;79(7):613-9. doi: 10.1016/j.biopsych.2016.01.004. Epub 2016 Jan 19.